Frontotemporal Degeneration Support Group/Dr. Richard Holub Drug Trial/Study Presentation
Join us for our next Frontotemporal Degeneration Meeting scheduled for April 30th at 5 PM at Beacon Pointe Memory Care. Guest Dr. Richard Holub, will discussing his new trial entitled “Safety and Efficacy Study Evaluating TRx0237 in Subjects with Behavioral Variant Frontotemporal Degeneration”. Learn more about the TRx0237 drug and its possible effects, eligibility for participation, and more. Dr. Holub is neurologist based in Albany, NY.
Created by ljacobi
One Emma Ln.
Clifton Park, NY 12065